Privacy
Swoop
Privacy Presents Challenges — and Opportunities for Change
To get ahead of recent changes to the healthcare marketing landscape, rely on offline privacy-safe health data.
Swoop
Android Announcement Compels Health Marketers to Use RWD
Google will end app tracking on Android, negatively impacting marketing – health marketers can avoid this with real world data, a privacy-safe solution.
Swoop
Google’s Latest Cookie-Less Solution Falls Short for Health Marketers
Google has changed its plan on cookies yet again, however, health marketers who adopt offline RWD-based patient segments will not be affected.
Swoop
Apple’s iOS Update Compels Health Marketers to Adopt Digital Audiences
Apple is compelling health marketers to adopt privacy-safe, AI-generated digital audiences created from offline RWD instead of online clickstream data.
Ron Elwell
Is There Life for Health Marketers After Facebook?
Facebook has sunsetted targeting for sensitive conditions; health marketers who rely on privacy-safe RWD segments are unaffected by this change.
Swoop
Protecting Patient Privacy Beyond HIPAA
The Network Advertising Initiative (NAI) protects patient privacy where HIPAA falls short, guaranteeing that audience segments are safe for marketers.
Scott Rines
Developing a Privacy Conscience
Privacy issues are unavoidable, but are you prepared? Health marketers must develop deep awareness of their company, patient & advertising supply chain.
Ron Elwell
New NAI Health Audience Disclosure Requirements
Swoop is an NAI member & must now disclose the demographic makeup & intended condition of its custom built audience of patients & healthcare providers.
Swoop
Swoop Granted Patent for Privacy by Design Data Processing Technique
Swoop's patented system of engagement uses privacy-safe ML & AI in conjunction with RWD to create precise patient & healthcare provider target audiences
Swoop
Developing a Privacy Conscience: Avoiding a Cambridge Analytica-Type Crisis (Or at Least Be Prepared for One)
The mission of the pharmaceutical industry is straightforward: Educate patients about disease states and the therapies that could effectively treat their conditions, as well as enable them to become active participants in their medical journey. But while the “what” pharmaceutical companies can say and the “how” they must say it is well regulated by the […]